The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot studyMateus Paiva Marques Feitosa, Carlos Serrano, Neuza Lopes et al.|Diabetology & Metabolic Syndrome|2023Cited by 25
The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot studyMateus Paiva Marques Feitosa, Carlos Serrano, Eduardo Gomes Lima et al.|Research Square|2023Cited by 2